On its third quarter of 2026 earnings call, held on Oct. 21, 2026, Abbott (ABT -1.89%) announced its plan to spin off its nutrition business into an independent public company. Shedding consumer nutrition sharpens focus on higher-margin medical technologies and diagnostics. The move leaves behind an enterprise with faster underlying sales expansion. Three takeaways from the call stand out. 3. Pulsed Field Ablation Powers Electrophysiology Expansion New catheter technology and expanding regulatory approvals ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

Abbott Laboratories NYSE: ABT reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%, while announcing plans to separate its nutrition business into an independent publicly traded company through a tax-free distribution to shareholders.Chairman and Chief Executive Officer Robert Ford said the planned separation follows a strategic review and is intended to give both businesses greater operational focus. The company expects to complete the transaction by the end of next year, ...

Abbott Laboratories reports third-quarter 2026 results before the market opens on October 21, 2026. Abbott Laboratories sells medical devices, diagnostic tests, nutrition products, and medicines. Adjusted earnings are $1.42 per share, matching estimates. Revenue is $13.01 billion, slightly above the $12.99 billion estimate. Abbott reports sales growth of 14.5% and comparable sales growth of 7.0%. Comparable sales growth includes Exact Sciences, which Abbott acquired on March 23, 2026. Under standard account ...

Key Takeaways Abbott's Q3 adjusted EPS missed estimates by 0.7%, while sales rose 14.5% to $13.01 billion.Abbott's Medical Devices and Diagnostics posted growth, while Nutrition sales rose 4.9% on a comparable basis.Abbott expanded gross and operating margins but lowered its 2026 comparable sales growth outlook to 6%.Abbott (ABT) reported third-quarter 2026 adjusted earnings per share of $1.42, up 9.2% year over year. The figure missed the Zacks Consensus Estimate by 0.7%.Sales increased 14.5% year over yea ...

印度食品监管机构已就误导性宣传向雀巢、Zydus Wellness和雅培健康发出通知。 ...

Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings call October 21, 2026 09:00 AM ET Company ParticipantsMike Comilla - VP of Investor RelationsRobert Ford - Chairman and CEOPhil Boudreau - EVP of Finance and CFOConference Call ParticipantsRobert Marcus - AnalystLarry Biegelsen - AnalystPatrick Wood - AnalystMatt Taylor - AnalystVijay Kumar - AnalystTravis Steed - AnalystJoanne Wuensch - AnalystOperatorGood morning, and thank you for standing by. Welcome to Abbott's Third Quarter 2026 Earnings Conference Call. ...

Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings call October 21, 2026 09:00 AM ET Speaker0Good morning, and thank you for standing by. Welcome to Abbott's third quarter 2026 earnings conference call. All participants will be able to listen only until the question and answer portion of this call. During the question and answer session, you will be able to ask your question by pressing the star 11 keys on your touchtone phone. This call is being recorded by Abbott. With the exception of any participant's ques ...

My top 10 things to watch Wednesday, Oct. 21 — Today's newsletter was written by Jeff Marks, the Club's director of portfolio analysis. 1. Stock futures are higher across the board this morning. The biggest gains are in the Nasdaq , which is getting a boost from SpaceX's 8% post-earnings pop and gains in chip stocks. Oil prices and bond yields are mostly steady and not standing in the way of stocks. 2. Elon Musk's SpaceX turned in a much better-than-expected quarter. Each reporting segment — Space, Connecti ...

Abbott plans to separate its nutrition business into an independent company with about $8.5 billion in annual sales. ...